fate therapeutics stock price target

Fate Therapeutics stock forecasts are adjusted once a day. Fate Therapeutics Stock Forecast Open Broker Account NASDAQFATE.

Fate Therapeutics Stock Nasdaq Fate Analyst Ratings Price Targets Predictions Benzinga

FATE IEX Real-Time Price USD 2132.

. The Fate Therapeutics stock prediction results are shown below and presented as a graph table and text information. FATE stock quote history news and other vital information to help you with your stock trading and investing. The latest price target for.

FATE was reported by Morgan Stanley on Friday. The forecasts range from a low of 2800 to a high of. Dulac III sold 5135 shares of Fate Therapeutics stock in a transaction that occurred on.

Negative dynamics for Fate Therapeutics shares will prevail with possible volatility of 4045. Forecast target price for 10-21-2022. Stock Price Target FATE.

Fate Therapeutics Stock Forecast 10-21-2022. Fate Therapeutics stock forecasts are adjusted once a day. In the context of stocks in the.

NASDAQFATEs beta value is holding at 166 while the average true range ATR indicator is currently reading 156. The 23 analysts offering price forecasts for Fate Therapeutics have a median target of 8783 with a high estimate of 13000 and a low estimate of 2800. FATE updated stock price target summary.

Find the latest Fate Therapeutics Inc. Fate Therapeutics Inc. 8 Wall Street analysts that have issued a 1 year FATE price target the average FATE price target is 7150.

Finally Morgan Stanley lowered their price target on shares of Fate Therapeutics from 4500 to 3500 and set an equal weight rating for the company in a report on Friday. The Fate Therapeutics stock prediction results are shown below and presented as a graph table and text information. Based on 11 Wall Street analysts offering 12 month price targets for Fate Therapeutics in the last 3 months.

FATE was reported by Morgan Stanley on September 9 2022The analyst firm set a price target for 3500 expecting. Analyst ratings historical stock prices earnings estimates actuals. The average Fate Therapeutics stock price prediction forecasts.

ET by Tomi Kilgore Fate Therapeutics upgraded to outperform from neutral at Wedbush price. Find the latest Fate Therapeutics Inc. Fate Therapeutics Inc.

FATE stock quote history news and other vital information to help you with your stock trading and investing. They set a buy rating and a 4200 target price on the stock. What is the target price for Fate Therapeutics FATE stock.

A The latest price target for Fate Therapeutics NASDAQ. Fate Therapeutics stock price target cut to 75 from 125 at Truist Apr. The current analyst and expert consensus on Fate Therapeutics is Buy with 0 strong sell and 14 strong buy opinions.

The average price target is 7450 with a high forecast. Based on short-term price targets offered by 16 analysts the average price target for Fate Therapeutics comes to 7313. The current projected Fate Therapeutics target price consensus is 10387.

24 rows FATE has a greater upside potential average analyst target price relative to current price than 295373 of stocks in the mid market cap category. According to 28 stock analysts the average 12-month stock price. FATE Stock Price Prediction.

13 2022 at 709 am.

Sec Filing Fate Therapeutics Inc